143 related articles for article (PubMed ID: 2695001)
1. Extrapolation of pharmacological and toxicological data based on metabolic weight.
Van Miert AS
Arch Exp Veterinarmed; 1989; 43(4):481-8. PubMed ID: 2695001
[TBL] [Abstract][Full Text] [Related]
2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
3. Physiologically based pharmacokinetics (PBPK).
Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
[TBL] [Abstract][Full Text] [Related]
4. Toxic effects of brominated flame retardants in man and in wildlife.
Darnerud PO
Environ Int; 2003 Sep; 29(6):841-53. PubMed ID: 12850100
[TBL] [Abstract][Full Text] [Related]
5. Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults.
Pai MP
Pharmacotherapy; 2012 Sep; 32(9):856-68. PubMed ID: 22711238
[TBL] [Abstract][Full Text] [Related]
6. The concept of multispecies testing in industrial toxicology.
Zbinden G
Regul Toxicol Pharmacol; 1993 Feb; 17(1):85-94. PubMed ID: 8441831
[TBL] [Abstract][Full Text] [Related]
7. Toxic effects of chemicals: difficulties in extrapolating data from animals to man.
Garattini S
Crit Rev Toxicol; 1985; 16(1):1-29. PubMed ID: 3910353
[TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
9. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
10. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
Box RJ; Spielmann H
Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
[TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
12. Extrapolating from animal studies to the efficacy in humans of a pretreatment combination against organophosphate poisoning.
Levy A; Cohen G; Gilat E; Kapon J; Dachir S; Abraham S; Herskovitz M; Teitelbaum Z; Raveh L
Arch Toxicol; 2007 May; 81(5):353-9. PubMed ID: 17009047
[TBL] [Abstract][Full Text] [Related]
13. Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose.
Contrera JF; Matthews EJ; Kruhlak NL; Benz RD
Regul Toxicol Pharmacol; 2004 Dec; 40(3):185-206. PubMed ID: 15546675
[TBL] [Abstract][Full Text] [Related]
14. Interspecies allometric scaling. Part I: prediction of clearance in large animals.
Mahmood I; Martinez M; Hunter RP
J Vet Pharmacol Ther; 2006 Oct; 29(5):415-23. PubMed ID: 16958787
[TBL] [Abstract][Full Text] [Related]
15. Surface area to volume relationships of snakes support the use of allometric scaling for calculating dosages of pharmaceuticals.
Timm KI; Picton JS; Tylman B
Lab Anim Sci; 1994 Feb; 44(1):60-2. PubMed ID: 8007663
[TBL] [Abstract][Full Text] [Related]
16. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages.
Brent RL
Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):303-20. PubMed ID: 15505806
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics and metabolism of ivermectin in domestic animal species.
González Canga A; Sahagún Prieto AM; José Diez Liébana M; Martínez NF; Vega MS; Vieitez JJ
Vet J; 2009 Jan; 179(1):25-37. PubMed ID: 17851096
[TBL] [Abstract][Full Text] [Related]
18. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
19. Extrapolation of preclinical pharmacokinetic data to therapeutic drug use.
Rahmani R; Richard B; Fabre G; Cano JP
Xenobiotica; 1988 Jan; 18 Suppl 1():71-88. PubMed ID: 3344591
[TBL] [Abstract][Full Text] [Related]
20. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents).
Brent RL
Pediatrics; 2004 Apr; 113(4 Suppl):984-95. PubMed ID: 15060191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
